{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:25:08Z","timestamp":1792445108312,"version":"4.5.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Plasma cell myeloma (PCM) involving skin is rare and occurs in 1% to 4% of patients with PCM. We evaluated the clinicopathologic features, cytogenetic findings and clinical follow-up in a series of PCM cases with cutaneous involvement.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Cases of PCM with cutaneous involvement were retrospectively reviewed with clinical data.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Skin involvement in PCM occurred in older individuals (mean, 75 years) and was more frequent in men (7\/10 patients). All cases showed bone marrow involvement preceding the cutaneous lesions. Histopathologically, the infiltrate was plasmacytic (n = 5) or primitive or plasmablastic (n = 4), and 1 case showed predominantly lymphoplasmacytic features with cyclin D1 immunoreactivity and CCND1 gene rearrangement. Concurrent amyloid deposition was seen in one biopsy, and another case demonstrated coexisting squamous cell carcinoma. The most common immunophenotype was CD138+, CD20\u2013, and CD56+ with light chain restriction. Cytogenetic analysis (available for 7 cases) showed multiple hyperdiploid abnormalities. Follow-up was available for 8 cases (mean, 42 months; range, 11-156 months) and showed short-term disease-related death in 7 of 8 patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Cutaneous involvement in PCM demonstrates a diverse cytomorphologic spectrum with plasmacytic, plasmablastic, or lymphoplasmacytic features and may show concurrent amyloid deposition or neoplasms such as squamous cell carcinoma. Cutaneous involvement typically occurs late in the course of the disease and likely portends poor outcome.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajcp\/aqaa122","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T11:19:10Z","timestamp":1593083950000},"page":"106-116","source":"Crossref","is-referenced-by-count":14,"title":["Cutaneous Involvement in Plasma Cell Myeloma"],"prefix":"10.1093","volume":"155","author":[{"given":"Gauri","family":"Panse","sequence":"first","affiliation":[{"name":"Department of Dermatology, Yale School of Medicine, New Haven, CT"},{"name":"Department of Pathology, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Subtil","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Yale School of Medicine, New Haven, CT"},{"name":"Department of Pathology, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M","family":"McNiff","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Yale School of Medicine, New Haven, CT"},{"name":"Department of Pathology, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Earl J","family":"Glusac","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Yale School of Medicine, New Haven, CT"},{"name":"Department of Pathology, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine J","family":"Ko","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Yale School of Medicine, New Haven, CT"},{"name":"Department of Pathology, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjela","family":"Galan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Yale School of Medicine, New Haven, CT"},{"name":"Department of Pathology, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Myung","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Yale School of Medicine, New Haven, CT"},{"name":"Department of Pathology, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina L","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,9,4]]},"reference":[{"key":"2021010403500278500_CIT0001","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jaad.2017.08.054","article-title":"Prevalence and clinicopathologic characteristics of multiple myeloma with cutaneous involvement: a case series from Korea","volume":"78","author":"Woo","year":"2018","journal-title":"J Am Acad Dermatol."},{"key":"2021010403500278500_CIT0002","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archderm.1991.01680010079012","article-title":"Cutaneous manifestations of multiple myeloma","volume":"127","author":"Kois","year":"1991","journal-title":"Arch Dermatol."},{"key":"2021010403500278500_CIT0003","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.3109\/10428194.2015.1128542","article-title":"Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients","volume":"57","author":"Jurczyszyn","year":"2016","journal-title":"Leuk Lymphoma."},{"key":"2021010403500278500_CIT0004","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1001\/archderm.139.4.475","article-title":"Cutaneous involvement in multiple myeloma: a clinicopathologic, immunohistochemical, and cytogenetic study of 8 cases","volume":"139","author":"Requena","year":"2003","journal-title":"Arch Dermatol."},{"key":"2021010403500278500_CIT0005","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1111\/j.1365-4632.2011.05231.x","article-title":"Metastatic skin lesions of multiple myeloma presenting as two extraordinarily large subcutaneous tumors","volume":"52","author":"Karasawa","year":"2013","journal-title":"Int J Dermatol."},{"key":"2021010403500278500_CIT0006","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jaad.2015.12.028","article-title":"Cutaneous involvement in multiple myeloma (MM): a case series with clinicopathologic correlation","volume":"74","author":"Malysz","year":"2016","journal-title":"J Am Acad Dermatol."},{"key":"2021010403500278500_CIT0007","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1346-8138.2012.01547.x","article-title":"Cutaneous involvement in multiple myeloma: report of two cases","volume":"39","author":"Messeguer","year":"2012","journal-title":"J Dermatol."},{"key":"2021010403500278500_CIT0008","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/ccr3.1626","article-title":"Multiple myeloma with simultaneous cutaneous and central nervous system involvement","volume":"6","author":"Nguyen","year":"2018","journal-title":"Clin Case Rep."},{"key":"2021010403500278500_CIT0009","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/archderm.1982.01650230050027","article-title":"Multiple myeloma first observed as multiple cutaneous plasmacytomas","volume":"118","author":"Shah","year":"1982","journal-title":"Arch Dermatol."},{"key":"2021010403500278500_CIT0010","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1346-8138.1999.tb02053.x","article-title":"Metastatic cutaneous plasmacytoma: a case report associated with IgA lambda multiple myeloma and a review of the literature of metastatic cutaneous plasmacytomas associated with multiple myeloma and primary cutaneous plasmacytomas","volume":"26","author":"Kato","year":"1999","journal-title":"J Dermatol."},{"key":"2021010403500278500_CIT0011","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1600-0560.2011.01779.x","article-title":"Hypertrophic lupus erythematosus: the diagnostic utility of CD123 staining","volume":"38","author":"Ko","year":"2011","journal-title":"J Cutan Pathol."},{"key":"2021010403500278500_CIT0012","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/his.13817","article-title":"Utility of CD123 immunohistochemistry in differentiating lupus erythematosus from cutaneous T cell lymphoma","volume":"74","author":"Chen","year":"2019","journal-title":"Histopathology."},{"key":"2021010403500278500_CIT0013","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jaad.2015.12.050","article-title":"Clusters of CD123+ plasmacytoid dendritic cells help distinguish lupus alopecia from lichen planopilaris","volume":"74","author":"Kolivras","year":"2016","journal-title":"J Am Acad Dermatol."},{"key":"2021010403500278500_CIT0014","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/apm.12845","article-title":"IgG4-related disease: review of the histopathologic features, differential diagnosis, and therapeutic approach","volume":"126","author":"Bledsoe","year":"2018","journal-title":"APMIS."},{"key":"2021010403500278500_CIT0015","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/ijd.13369","article-title":"IgG4-related skin disease may have distinct systemic manifestations: a systematic review","volume":"55","author":"Bennett","year":"2016","journal-title":"Int J Dermatol."},{"key":"2021010403500278500_CIT0016","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2133.2011.10314.x","article-title":"Comparative analysis of immunohistochemistry, polymerase chain reaction and focus-floating microscopy for the detection of Treponema pallidum in mucocutaneous lesions of primary, secondary and tertiary syphilis","volume":"165","author":"M\u00fcller","year":"2011","journal-title":"Br J Dermatol."},{"key":"2021010403500278500_CIT0017","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/cup.13143","article-title":"Detection of Borrelia in Ixodes scapularis ticks by silver stain, immunohistochemical and direct immunofluorescent methods","volume":"45","author":"Galan","year":"2018","journal-title":"J Cutan Pathol."},{"key":"2021010403500278500_CIT0018","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/ajt.14731","article-title":"Plasma cell diseases and organ transplant: a comprehensive review","volume":"18","author":"Cowan","year":"2018","journal-title":"Am J Transplant."},{"key":"2021010403500278500_CIT0019","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/cup.13499","article-title":"Plasmacytic cutaneous pathology: a review","volume":"46","author":"Walsh","year":"2019","journal-title":"J Cutan Pathol."},{"key":"2021010403500278500_CIT0020","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/PAS.0000000000000234","article-title":"Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases","volume":"38","author":"Morscio","year":"2014","journal-title":"Am J Surg Pathol."},{"key":"2021010403500278500_CIT0021","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1080\/10428194.2017.1393666","article-title":"Primary cutaneous plasmablastic lymphoma in an immunocompetent patient: is it associated with an indolent course?","volume":"59","author":"Beltran","year":"2018","journal-title":"Leuk Lymphoma."},{"key":"2021010403500278500_CIT0022","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2559.2005.01985.x","article-title":"Plasmablastic lymphoma arising at a cutaneous site","volume":"46","author":"Jordan","year":"2005","journal-title":"Histopathology."},{"key":"2021010403500278500_CIT0023","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1365-2133.2003.05544.x","article-title":"Post-transplant plasmablastic lymphoma of the skin","volume":"149","author":"Nicol","year":"2003","journal-title":"Br J Dermatol."},{"key":"2021010403500278500_CIT0024","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1525-1470.2009.01019.x","article-title":"Cutaneous presentation of plasmablastic post-transplant lymphoproliferative disorder in a 14-month-old","volume":"26","author":"Hernandez","year":"2009","journal-title":"Pediatr Dermatol."},{"key":"2021010403500278500_CIT0025","first-page":"2090","article-title":"Epstein-Barr virus-positive multiple myeloma developing after immunosuppressant therapy for rheumatoid arthritis: a case report and review of literature","volume":"8","author":"Sekiguchi","year":"2015","journal-title":"Int J Clin Exp Pathol."},{"key":"2021010403500278500_CIT0026","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1309\/BVT4-YP41-LCV2-5GT0","article-title":"Cyclin D1 overexpression in multiple myeloma: a morphologic, immunohistochemical, and in situ hybridization study of 71 paraffin-embedded bone marrow biopsy specimens","volume":"116","author":"Athanasiou","year":"2001","journal-title":"Am J Clin Pathol."},{"key":"2021010403500278500_CIT0027","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1182\/blood.V99.10.3735","article-title":"Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients","volume":"99","author":"Fonseca","year":"2002","journal-title":"Blood."},{"key":"2021010403500278500_CIT0028","doi-asserted-by":"crossref","first-page":"580","DOI":"10.5858\/arpa.2012-0034-RS","article-title":"Lymphoplasmacytic lymphoma and Waldenstr\u00f6m macroglobulinemia","volume":"137","author":"Naderi","year":"2013","journal-title":"Arch Pathol Lab Med."},{"key":"2021010403500278500_CIT0029","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/bjh.15426","article-title":"Second primary malignancy after multiple myeloma-population trends and cause-specific mortality","volume":"182","author":"Costa","year":"2018","journal-title":"Br J Haematol."},{"key":"2021010403500278500_CIT0030","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/ejh.12748","article-title":"Risk of skin cancer in multiple myeloma patients: a retrospective cohort study","volume":"97","author":"Robinson","year":"2016","journal-title":"Eur J Haematol."},{"key":"2021010403500278500_CIT0031","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bjps.2003.11.021","article-title":"A case of squamous cell carcinoma associated with plasmacytoma","volume":"57","author":"Jayagopal","year":"2004","journal-title":"Br J Plast Surg."},{"key":"2021010403500278500_CIT0032","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.tripleo.2009.03.048","article-title":"Synchronous oral squamous cell carcinoma and extramedullary plasmacytoma of the tonsil","volume":"108","author":"Junquera","year":"2009","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod."},{"key":"2021010403500278500_CIT0033","first-page":"1463218","article-title":"Concomitant extramedullary plasmacytoma in the oropharynx and hypopharyngeal squamous cell carcinoma","volume":"2018","author":"Sato","year":"2018","journal-title":"Case Rep Otolaryngol."},{"key":"2021010403500278500_CIT0034","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.hemonc.2018.09.003","article-title":"Cutaneous light chain amyloidosis with multiple myeloma: a concise review","volume":"12","author":"Andrei","year":"2019","journal-title":"Hematol Oncol Stem Cell Ther."},{"key":"2021010403500278500_CIT0035","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/j.seminoncol.2016.02.017","article-title":"Cutaneous manifestations of multiple myeloma and other plasma cell proliferative disorders","volume":"43","author":"Bhutani","year":"2016","journal-title":"Semin Oncol."},{"key":"2021010403500278500_CIT0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0190-9622(88)70001-8","article-title":"Amyloid and amyloidosis","volume":"18","author":"Breathnach","year":"1988","journal-title":"J Am Acad Dermatol."},{"key":"2021010403500278500_CIT0037","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00277-010-1028-8","article-title":"Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma: a series of 144 cases and a review of the literature","volume":"90","author":"Siragusa","year":"2011","journal-title":"Ann Hematol."},{"key":"2021010403500278500_CIT0038","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00277-009-0857-9","article-title":"Amyloid in bone marrow smears of patients affected by multiple myeloma","volume":"89","author":"Petruzziello","year":"2010","journal-title":"Ann Hematol."},{"key":"2021010403500278500_CIT0039","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/ajh.23828","article-title":"Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment","volume":"89","author":"Gertz","year":"2014","journal-title":"Am J Hematol."},{"key":"2021010403500278500_CIT0040","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/cup.12413","article-title":"Cutaneous crystal storing histiocytosis: a report of two cases","volume":"42","author":"Li","year":"2015","journal-title":"J Cutan Pathol."},{"key":"2021010403500278500_CIT0041","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3109\/10428194.2012.671481","article-title":"Type I cryoglobulinemia in multiple myeloma, a rare entity: analysis of clinical and biological characteristics of seven cases and review of the literature","volume":"54","author":"Payet","year":"2013","journal-title":"Leuk Lymphoma."},{"key":"2021010403500278500_CIT0042","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/ajd.12696","article-title":"Crystalglobulinaemia: multiple myeloma presenting with cutaneous and neurological manifestations","volume":"59","author":"Thornton","year":"2018","journal-title":"Australas J Dermatol."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/155\/1\/106\/35373943\/aqaa122.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/155\/1\/106\/35373943\/aqaa122.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T08:50:21Z","timestamp":1609750221000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/155\/1\/106\/5901373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,4]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,9,4]]},"published-print":{"date-parts":[[2021,1,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqaa122","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1,1]]},"published":{"date-parts":[[2020,9,4]]}}}